Literature DB >> 7860747

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

A Muir1, A Peck, M Clare-Salzler, Y H Song, J Cornelius, R Luchetta, J Krischer, N Maclaren.   

Abstract

We reported previously that daily injections of isophane insulin prevented both hyperglycemia and insulitis in nonobese diabetic (NOD) mice (Atkinson, M., N. Maclaren; and R. Luchetta. 1990. Diabetes. 39:933-937). The possible mechanisms responsible include reduced immunogenicity of pancreatic beta-cells from "beta-cell rest" and induced active immunoregulation to insulin (Aaen, IK., J. Rygaard, K. Josefsen, H. Petersen, C. H. Brogren, T. Horn, and K. Buschard. 1990. Diabetes. 39:697-701). We report here that intermittent immunizations with insulin or its metabolically inactive B-chain in incomplete Freund's adjuvant also prevent diabetes in NOD mice, whereas immunizations with A-chain insulin or with BSA do not. Adoptive transfer of splenocytes from B-chain insulin-immunized mice prevented diabetes in recipients co-infused with diabetogenic spleen cells, an effect that was abolished by prior in vivo elimination of either CD4+ or CD8+ cells. Insulin immunization did not reduce the extent of intraislet inflammation (insulitis); however, it did abolish expression of IFN-gamma mRNA within the insulitis lesions. Immunizations with insulin thus induce an active suppressive response to determinants on the B-chain that converts the insulitis lesion from one that is destructive to one that is protective.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860747      PMCID: PMC295528          DOI: 10.1172/JCI117707

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.

Authors:  M A Atkinson; N K Maclaren; R Luchetta
Journal:  Diabetes       Date:  1990-08       Impact factor: 9.461

2.  CD4 monoclonal antibody pairs for immunosuppression and tolerance induction.

Authors:  S Qin; S Cobbold; H Tighe; R Benjamin; H Waldmann
Journal:  Eur J Immunol       Date:  1987-08       Impact factor: 5.532

3.  Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.

Authors:  O Lider; L M Santos; C S Lee; P J Higgins; H L Weiner
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

4.  A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media.

Authors:  A B Peck; F H Bach
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

5.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

Review 6.  Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

Authors:  A Muir; D Schatz; N Maclaren
Journal:  Diabetes Metab Rev       Date:  1993-12

7.  Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals.

Authors:  C F Gotfredsen; K Buschard; E K Frandsen
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

8.  Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression.

Authors:  Y M Kong; A A Giraldo; H Waldmann; S P Cobbold; B E Fuller
Journal:  Clin Immunol Immunopathol       Date:  1989-04

9.  IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans.

Authors:  I L Campbell; A Iscaro; L C Harrison
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

10.  Insulin antibodies in insulin-dependent diabetics before insulin treatment.

Authors:  J P Palmer; C M Asplin; P Clemons; K Lyen; O Tatpati; P K Raghu; T L Paquette
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

View more
  51 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.

Authors:  J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

3.  T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes.

Authors:  D Dubois-LaForgue; J C Carel; P F Bougnères; J G Guillet; C Boitard
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 4.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 5.  Autoimmune diabetes: more than just one flavor?

Authors:  H K Chiu; J P Palmer
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

6.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 7.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

8.  The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

Authors:  Wei Hao; Carla J Greenbaum; Jeffrey P Krischer; David Cuthbertson; Jennifer B Marks; Jerry P Palmer
Journal:  Diabetes Care       Date:  2015-02-26       Impact factor: 19.112

Review 9.  Auto-antigen and Immunomodulatory Agent-Based Approaches for Antigen-Specific Tolerance in NOD Mice.

Authors:  Ethan J Bassin; Jon D Piganelli; Steven R Little
Journal:  Curr Diab Rep       Date:  2021-02-06       Impact factor: 4.810

10.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.